Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphomaMatthew J. Frigault, Marcela V. Maus, Jörg Dietrich et al.|Blood|2019Cited by 237
Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter studyJorge J. Castillo, Steven P. Treon, Dipti Talaulikar et al.|Blood|2018Cited by 100
Clinical efficacy and safety of chimeric antigen receptor T‐cell therapy for mantle cell lymphoma with secondary central nervous system involvementChristine E. Ryan, Reid W. Merryman, Rebecca L. Zon et al.|British Journal of Haematology|2023Cited by 16
Relapsed diffuse large B-cell lymphoma is shaped by molecular subtypes and genomic alterationsEleonora Calabretta, Margaret A. Shipp, Xuan Zhao et al.|Blood|2025Cited by 1
330 | IDENTIFICATION OF GENOMIC PREDICTORS OF SURVIVAL IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMASElisa Aquilanti, Lakshmi Nayak, T. Aramburu et al.|Hematological Oncology|2025Cited by 0